University of Vermont

Clinical Simulation Laboratory

Bio for Ted A. James, MD FACS
Ted A. James, MD FACS

Ted A. James, MD FACS

Director of Clinical Simulation
Associate Professor of Surgery
Division of Surgical Oncology

Contact Information
Office Location:
Surgery - Oncology, Given B227


Drexel University/Medical College of Pennsylvania, Philadelphia, PA, 1992-1996
Residency in General Surgery, North Shore University Hospital, Manhasset, NY, 1996-2003
Fellowship in Molecular Biology/Cellular Engineering, Boas Marks Medical Research Center, Manhasset, NY, 1997-1998
Fellowship in Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, 2003-2005

Academic Appointments

Director of Clinical Simulation, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT  2012-present
Associate Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT   2011-present
Assistant Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT   2005- 2010

Research Grants

New York University School of Medicine     1/7/10-12/31/10
Randomized Trial of Educational Outcomes of Web Initiative
 in surgical education. Proposal #: 24125.
Amount: $3,991. Role: Local PI

National Institute of Health (NCI Challenge Grant)    9/30/09-8/31/11
‘Improving breast cancer surgery quality through a collaborative
 surgery database’
Grant Number: 1RC1CA145402-01.
Amount: $1,280,221. Role: Local PI: 5%
National Institute of Health (National Cancer Institute)    9/30/09-7/31/11
‘Measuring quality of breast cancer surgery’
Amount: $3,141,962. Role: Co-Investigator: 10%
Dept. of Health and Human Resources (HRSA Grant)    9/1/09-8/31/10
‘Simulation scenario development’
Amount: $471,240.00. Role: Co-investigator: 10%

Vermont Experimental Program to Stimulate Competitive Research  10/1/08-6/1/09
‘Delivery of chemotherapeutic agents to human malignant melanoma cells
   using nanoporous silica particles’ (SBIR phase 0)
Amount: $12,000. Role: Principle Investigator.

Vermont Experimental Program to Stimulate Competitive Research  10/1/08-6/1/09
‘Evaluation of FTIR spectroscopy for breast cancer diagnosis
   and molecular characterization’ (SBIR phase 0)
Amount: $12,000. Role: Co-investigator/Clinical Consultant.

National Institute of Health (National Cancer Institute)    8/1/06-8/31/09 
‘Breast cancer stamp fund: molecular epidemiology and biology
   of mammographic density: A pilot study to evaluate protocol feasibility’
Role: Clinical Consultant

Small Business Technology Transfer Grant     10/07-09/09
Improving the transfer of ERK siRNA constructs using
   nanoporous silica. Apollo SRI, LLC / University of Vermont
Role: Clinical Consultant

University of Vermont - Department of Surgery Research Grant    7/1/06-7/1/08
‘Nanoporous particles as molecular delivery agents in melanoma’
Amount: $10,850. Role: Principal Investigator

University of Vermont - Department of Surgery Research Grant   7/1/06-7/1/08
‘Novel prognostic and diagnostic markers in human melanoma’
Amount $12,104. Role: Principal Investigator

Awards and Honors

Research Fellowship Sponsor (Medical Student: S. Persing)   2010
University of Vermont, College of Medicine

Jerome S. Abrams Teaching Award       2009
Department of Surgery, University of Vermont

Cancer Liaison Physician Outstanding Performance Award   2008
Commission on Cancer

Leadership Scholarship Award  2008
American College of Surgeons 

Thoracic Surgery Oncology Fellowship Award  2005
Roswell Park Cancer Institute


Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer. 2014 Jan;50(1):185-92.

Onitilo AA, Onesti JK, Single RM, Engel JM, James TA, Aiello Bowles EJ, Feigelson HS, Barney T, McCahill LE. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer. PLoS One. 2013 Dec 20;8(12):e84535.

Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM. Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 U.S. Preventive Services Task Force Recommendations. Radiology. 2013 Sep 26. [Epub ahead of print]

Yarger JB, James TA, Ashikaga T, Hayanga AJ, Takyi V, Lum Y, Kaiser H, Mammen J. Characteristics in response rates for surveys administered to surgery residents. Surgery 2013 Jul;154(1):38-45.

Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, Bakerman JE, McCahill LE. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013 May;216(5):966-75. doi: 10.1016/j.jamcollsurg.2013.01.011. Epub 2013 Mar 13.

James TA, Mace JL, Virnig BA, Geller BM. Preoperative needle biopsy improves the quality of breast cancer surgery. J Am Coll Surg 2012;215(4):562-8.

Aiello Bowles EJ, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K, Engel J, Gundersen G, Sheehey-Jones J, Single R, Onitilo A, James TA, McCahill LE. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC Cancer. 2012;12:136.

McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, Onitilo AA. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5):467-75.

Persing S, James TA, Mace J, Geller B. Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann Surg Oncol 2011;18:(11):3061-5.

James TA, McCahill LE. Variant Mastectomy Rates: Implications for quality of care in breast cancer surgery. J Clin Oncol. 2010 Jul 20;28(21):e364; author reply e365.

James TA, McCahill LE, et al., Quality Assessment of Neoadjuvant Therapy Use in Breast Conservation: Barriers to Implementation. Breast J. 2009 Sep-Oct;15(5):524-6.

McCahill LE, Privette A, James T, Sheehey-Jones J, Ratliff J, Majercik D, Krag DN, Stanley M, Harlow S. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144(5):455-62.

McCahill LE, Hart MR,  Privette AR, James TA. Are Mastectomy Rates a Reasonable Measure of Quality for Breast Cancer Surgery? Am J Surg. 2009;197(2):216-21.

James TA, Harlow S, Sheehey-Jones J, Hart M, Gaspari C, Stanley M, Krag D, Ashikaga Takamaru, McCahill LE.  Intraoperative Ultrasound versus Mammographic Needle Localization for Ductal Carcinoma In-Situ. Ann Surg Oncol. 2009;16(5):1164-9.

James TA, May J. Breast Cancer Nutrition. Cancer Updates, Research and Education,  2008.

James TA. From the Chair; Training in Essential Non-Clinical Skills. Bulletin of the American College of Surgeons. 2008 Jul;93(7):10-1.